Abstract:Background: Following partial injury to the central nervous system, cells beyond the initial injury site undergo secondary degeneration, exacerbating loss of neurons, compact myelin and function. Changes in Ca2+ flux are associated with metabolic and structural changes, but it is not yet clear how flux through specific ion channels contributes to the various pathologies. Here, partial optic nerve transection in adult female rats was used to model secondary degeneration. Treatment with combinations of three ion channel inhibitors was used as a tool to investigate which elements of oxidative and structural damage related to long term functional outcomes. The inhibitors employed were the voltage gated Ca2+ channel inhibitor Lomerizine (Lom), the Ca2+ permeable AMPA receptor inhibitor YM872 and the P2X7 receptor inhibitor oxATP. Results: Following partial optic nerve transection, hyper-phosphorylation of Tau and acetylated tubulin immunoreactivity were increased, and Nogo-A immunoreactivity was decreased, indicating that axonal changes occurred acutely. All combinations of ion channel inhibitors reduced hyper-phosphorylation of Tau and increased Nogo-A immunoreactivity at day 3 after injury. However, only Lom/oxATP or all three inhibitors in combination significantly reduced acetylated tubulin immunoreactivity. Most combinations of ion channel inhibitors were effective in restoring the lengths of the paranode and the paranodal gap, indicative of the length of the node of Ranvier, following injury. However, only all three inhibitors in combination restored to normal Ankyrin G length at the node of Ranvier. Similarly, HNE immunoreactivity and loss of oligodendrocyte precursor cells were only limited by treatment with all three ion channel inhibitors in combination. Conclusions: Data indicate that inhibiting any of a range of ion channels preserves certain elements of axon and node structure and limits some oxidative damage following injury, whereas ionic flux through all three channels must be inhibited to prevent lipid peroxidation and preserve Ankyrin G distribution and OPCs.

From Myelin Debris to Inflammatory Responses: a Vicious Circle in Diffuse Axonal Injury.

Involvement of Toll Like Receptor 2 Signaling in Secondary Injury During Experimental Diffuse Axonal Injury in Rats

Microglia: A Potential Drug Target for Traumatic Axonal Injury

Inhibition of TLR4 Signalling-Induced Inflammation Attenuates Secondary Injury after Diffuse Axonal Injury in Rats

The Occurrence of Diffuse Axonal Injury in the Brain: Associated with the Accumulation and Clearance of Myelin Debris

Inflammation & apoptosis in spinal cord injury.

Oxidative Stress and Inflammatory Response in Early Stage of Diffuse Axonal Injury in Rats

Myelin Activates Fak/Akt/Nf-Kappa B Pathways and Provokes Cr3-Dependent Inflammatory Response in Murine System

Dynamic expression and distribution of high mobility group box 1 in diffuse axonal injury in rats

Inhibition of Macrophage Migration Inhibitory Factor Protects Against Inflammation Through a Toll-like Receptor-Related Pathway after Diffuse Axonal Injury in Rats

Research advances of secondary brain injury caused by diffuse axonal injury and its therapeutic strategies

iTRAQ-based proteomic analysis discovers potential biomarkers of diffuse axonal injury in rats

Role of Monocyte/macrophage in Secondary Disruption of Nondisruptive Axonal Injury Caused by Fluid Percussion

Molecular dynamics study of stiffness and rupture of axonal membranes

Function of Microglia and Macrophages in Secondary Damage after Spinal Cord Injury

Demyelination as a rational therapeutic target for ischemic or traumatic brain injury.

Diffuse Axonal Injury: Novel Insights into Detection and Treatment

Inflammatory response in traumatic brain and spinal cord injury: The role of XCL1‐XCR1 axis and T cells

Acute and non-resolving inflammation associate with oxidative injury after human spinal cord injury

Specific ion channels contribute to key elements of pathology during secondary degeneration following neurotrauma

Development of inflammatory factors on spinal cord injury